V
Virpax Pharmaceuticals D
D
VRPX
0.65000
USD
0.03
(4.82%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-0
Market Cap
3,176,928
News
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Virpax Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.